79 related articles for article (PubMed ID: 15239142)
1. Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes.
Tanaka T; Tanimoto K; Otani K; Satoh K; Ohtaki M; Yoshida K; Toge T; Yahata H; Tanaka S; Chayama K; Okazaki Y; Hayashizaki Y; Hiyama K; Nishiyama M
Int J Cancer; 2004 Sep; 111(4):617-26. PubMed ID: 15239142
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data.
Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Noguchi T; Kawahara K; Natsugoe S; Aikou T; Okazaki Y; Hayashizaki Y; Sato Y; Todo S; Hiyama E; Nishiyama M
Int J Oncol; 2006 May; 28(5):1153-62. PubMed ID: 16596231
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
4. Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levels.
Sano H; Wada S; Eguchi H; Osaki A; Saeki T; Nishiyama M
Breast Cancer; 2012 Jan; 19(1):37-45. PubMed ID: 21437666
[TBL] [Abstract][Full Text] [Related]
5. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
6. Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
Fumoto S; Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Hiyama E; Noguchi T; Nishiyama M
Int J Oncol; 2008 Feb; 32(2):413-23. PubMed ID: 18202764
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
Ooyama A; Takechi T; Toda E; Nagase H; Okayama Y; Kitazato K; Sugimoto Y; Oka T; Fukushima M
Cancer Sci; 2006 Jun; 97(6):510-22. PubMed ID: 16734730
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
[TBL] [Abstract][Full Text] [Related]
10. Prediction of doxorubicin sensitivity in gastric cancers based on a set of novel markers.
Liu H; Li N; Yao L; Jiang L; Bao G; Li J; Ma Q; Liu Z
Oncol Rep; 2008 Oct; 20(4):963-9. PubMed ID: 18813841
[TBL] [Abstract][Full Text] [Related]
11. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
Kodera Y; Ito S; Fujiwara M; Mochizuki Y; Nakayama G; Ohashi N; Koike M; Yamamura Y; Nakao A
Cancer Lett; 2007 Jul; 252(2):307-13. PubMed ID: 17303323
[TBL] [Abstract][Full Text] [Related]
13. Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer.
Jeung HC; Rha SY; Shin SJ; Lim SJ; Roh JK; Noh SH; Chung HC
Anticancer Drugs; 2011 Sep; 22(8):801-10. PubMed ID: 21572321
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
[TBL] [Abstract][Full Text] [Related]
15. Alteration of gene expression and DNA methylation in drug-resistant gastric cancer.
Maeda O; Ando T; Ohmiya N; Ishiguro K; Watanabe O; Miyahara R; Hibi Y; Nagai T; Yamada K; Goto H
Oncol Rep; 2014 Apr; 31(4):1883-90. PubMed ID: 24504010
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile predicts patient survival of gastric cancer after surgical resection.
Chen CN; Lin JJ; Chen JJ; Lee PH; Yang CY; Kuo ML; Chang KJ; Hsieh FJ
J Clin Oncol; 2005 Oct; 23(29):7286-95. PubMed ID: 16145069
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
[TBL] [Abstract][Full Text] [Related]
18. DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer.
Kim HK; Choi IJ; Kim HS; Kim JH; Kim E; Park IS; Chun JH; Kim IH; Kim IJ; Kang HC; Park JH; Bae JM; Lee JS; Park JG
Biochem Biophys Res Commun; 2004 Apr; 316(3):781-9. PubMed ID: 15033468
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.
Behera RK; Nayak R
Cancer Invest; 2009 Jun; 27(5):561-7. PubMed ID: 19219653
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.
Györffy B; Surowiak P; Kiesslich O; Denkert C; Schäfer R; Dietel M; Lage H
Int J Cancer; 2006 Apr; 118(7):1699-712. PubMed ID: 16217747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
